NTX-001 is a potentially transformative adjunctive treatment for peripheral nerve injuries, using a propriety system for the reconnection of severed…
Continue ReadingNew Rhein Healthcare Investors invites you to join us for our event, Investing in Healthcare and Life Science Innovations, in Ghent, Belgium, on…
Continue ReadingNew Rhein Healthcare Investors invites you to join us for our event, Investing in Healthcare and Life Science Innovations, in Singapore on September…
Continue ReadingLAFAYETTE, Colo., Dec. 19, 2018 /PRNewswire/ -- Neuraptive Therapeutics, Inc. (Neuraptive) announced today that it has secured a $11.5 million Series A equity financing which remains…
Continue ReadingPHILADELPHIA, Dec. 12, 2018 /PRNewswire/ -- New Rhein Healthcare Investors, an international private equity firm has announced moving its global headquarters from Chicago to Philadelphia, complementing its other offices in…
Continue Reading
